vs
Side-by-side financial comparison of FLYEXCLUSIVE INC. (FLYX) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
FLYEXCLUSIVE INC. is the larger business by last-quarter revenue ($92.1M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 19.8%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-11.0M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 21.9%).
FLYEXCLUSIVE INC. is a U.S.-headquartered private aviation services provider that offers private jet charter, aircraft management, maintenance repair, and fractional ownership programs. It primarily serves high-net-worth individuals, corporate clients, and government entities across North America, delivering personalized on-demand air travel solutions prioritizing safety and convenience.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
FLYX vs PBYI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $92.1M | $75.5M |
| Net Profit | $-4.3M | — |
| Gross Margin | 13.7% | 69.3% |
| Operating Margin | -12.3% | 22.7% |
| Net Margin | -4.6% | — |
| Revenue YoY | 19.8% | 27.7% |
| Net Profit YoY | 32.0% | — |
| EPS (diluted) | $-0.25 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | $92.1M | $54.5M | ||
| Q2 25 | $91.3M | $52.4M | ||
| Q1 25 | $88.1M | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | $76.9M | $80.5M | ||
| Q2 24 | $79.0M | $47.1M | ||
| Q1 24 | $80.0M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-4.3M | $8.8M | ||
| Q2 25 | $-4.8M | $5.9M | ||
| Q1 25 | $-5.4M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-6.3M | $20.3M | ||
| Q2 24 | $-5.2M | $-4.5M | ||
| Q1 24 | $-5.8M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | 13.7% | 77.7% | ||
| Q2 25 | 15.0% | 76.5% | ||
| Q1 25 | 12.8% | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | 11.3% | 63.9% | ||
| Q2 24 | 7.9% | 77.4% | ||
| Q1 24 | 7.2% | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | -12.3% | 17.6% | ||
| Q2 25 | -13.5% | 12.7% | ||
| Q1 25 | -16.7% | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | -27.2% | 27.4% | ||
| Q2 24 | -27.6% | -4.6% | ||
| Q1 24 | -34.3% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | -4.6% | 16.2% | ||
| Q2 25 | -5.2% | 11.2% | ||
| Q1 25 | -6.2% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -8.2% | 25.2% | ||
| Q2 24 | -6.5% | -9.6% | ||
| Q1 24 | -7.3% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | $-0.25 | $0.17 | ||
| Q2 25 | $-0.26 | $0.12 | ||
| Q1 25 | $-0.30 | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $-0.32 | $0.41 | ||
| Q2 24 | $-0.32 | $-0.09 | ||
| Q1 24 | $-0.35 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.7M | $97.5M |
| Total DebtLower is stronger | $123.9M | $22.7M |
| Stockholders' EquityBook value | $-434.2M | $130.3M |
| Total Assets | $448.1M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | $18.7M | $94.4M | ||
| Q2 25 | $15.8M | $96.0M | ||
| Q1 25 | $14.7M | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | $18.7M | $96.7M | ||
| Q2 24 | $9.3M | $96.8M | ||
| Q1 24 | $5.3M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | $123.9M | $34.0M | ||
| Q2 25 | $111.6M | $45.3M | ||
| Q1 25 | $121.6M | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | $197.9M | $79.3M | ||
| Q2 24 | $206.3M | $90.7M | ||
| Q1 24 | $209.4M | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | $-434.2M | $115.3M | ||
| Q2 25 | $-261.4M | $104.7M | ||
| Q1 25 | $-281.5M | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | $-192.0M | $71.1M | ||
| Q2 24 | $-149.7M | $48.5M | ||
| Q1 24 | $-149.5M | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | $448.1M | $202.9M | ||
| Q2 25 | $443.4M | $194.9M | ||
| Q1 25 | $466.8M | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | $487.1M | $220.7M | ||
| Q2 24 | $494.7M | $205.0M | ||
| Q1 24 | $524.1M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-209.0K | $14.4M |
| Free Cash FlowOCF − Capex | $-11.0M | $14.4M |
| FCF MarginFCF / Revenue | -12.0% | 19.1% |
| Capex IntensityCapex / Revenue | 11.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-51.0M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-209.0K | $9.7M | ||
| Q2 25 | $363.0K | $14.1M | ||
| Q1 25 | $-10.5M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $-12.3M | $11.0M | ||
| Q2 24 | $-16.2M | $1.0M | ||
| Q1 24 | $-26.0M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-11.0M | $9.7M | ||
| Q2 25 | $353.0K | $14.1M | ||
| Q1 25 | $-14.6M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $-25.7M | $11.0M | ||
| Q2 24 | $-26.6M | $1.0M | ||
| Q1 24 | $-64.5M | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | -12.0% | 17.7% | ||
| Q2 25 | 0.4% | 26.8% | ||
| Q1 25 | -16.5% | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | -33.5% | 13.7% | ||
| Q2 24 | -33.7% | 2.1% | ||
| Q1 24 | -80.6% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 11.7% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 4.7% | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 17.5% | 0.0% | ||
| Q2 24 | 13.2% | 0.0% | ||
| Q1 24 | 48.2% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
